·
We employ state-of-the-art gene editing technologies, including CRISPR-Cas9, to modify genetic sequences associated with neurodegenerative diseases. This methodology allows us to create precise models for studying disease mechanisms and testing potential therapies, thereby advancing our understanding of these complex disorders.